PetVivo CEO buys 31,250 shares at $0.78
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PetVivo Holdings, Inc. (PETV) reported that its Chief Executive Officer and director John Lai acquired 31,250 shares of restricted common stock on September 9, 2026 at $0.78 per share in connection with a private placement investment pursuant to a subscription agreement. In a related step, on September 8–9, 2026 he converted warrants covering 31,250 shares of common stock at an exercise price of $1.10 per share, with the warrants scheduled to expire on September 9, 2029. Following these transactions, he directly holds 2,413,163 shares of PetVivo common stock. No transactions were reported under a Rule 10b5-1 trading plan.
Insider Trade Summary
31,250 shares exercised/converted
Exercise
2 txns
Insider
Lai John
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 31,250 | $0.78 | $24K |
| Conversion | Common Stock Warrant F1 | 31,250 | -- | -- |
Holdings After Transaction:
Common Stock Warrant — 31,250 contracts (Direct);
Common Stock — 2,413,163 shares (Direct)
Footnotes (1)
- F1. Represents the acquisition of restricted common stock and warrants by the Reporting Person in connection with a private placement investment in the Company pursuant to a subscription agreement.
Key Figures
Restricted common shares acquired: 31,250 shares
Acquisition price per restricted share: $0.78 per share
Common shares underlying converted warrants: 31,250 shares
+3 more
6 metrics
Restricted common shares acquired
31,250 shares
Restricted common stock acquired on September 9, 2026 in private placement investment
Acquisition price per restricted share
$0.78 per share
Price for restricted common stock acquired by John Lai on September 9, 2026
Common shares underlying converted warrants
31,250 shares
Shares of common stock underlying warrants converted in derivative transaction
Warrant exercise price
$1.10 per share
Exercise price of warrants converted into common stock
Warrant expiration date
September 9, 2029
Expiration date of the common stock warrants involved in the conversion
Direct common stock holdings after transactions
2,413,163 shares
John Lai’s direct PetVivo common stock ownership following the reported transactions
Key Terms
restricted common stock, private placement, subscription agreement, Common Stock Warrant
4 terms
restricted common stock financial
"Represents the acquisition of restricted common stock and warrants by the Reporting Person"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
private placement financial
"in connection with a private placement investment in the Company pursuant to a subscription agreement"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
subscription agreement financial
"investment in the Company pursuant to a subscription agreement"
A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.
Common Stock Warrant financial
"Common Stock Warrant reported as a derivative security with an expiration date"
A common stock warrant is a tradable right that lets its holder buy a company’s common shares at a fixed price within a set time period. For investors it acts like a long‑dated option: it can magnify gains if the share price rises above the fixed price, but it also creates potential dilution because new shares are issued when warrants are used, which can reduce the value of existing shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PetVivo (PETV) CEO John Lai acquire in this Form 4 filing?
John Lai acquired 31,250 shares of restricted common stock of PetVivo Holdings, Inc. on September 9, 2026 at $0.78 per share, as part of a private placement investment in the company pursuant to a subscription agreement.
Was John Lai’s PetVivo (PETV) transaction part of a private placement?
Yes. A footnote states that the transactions represent the acquisition of restricted common stock and warrants by John Lai in connection with a private placement investment in PetVivo Holdings, Inc. pursuant to a subscription agreement.
Were PetVivo (PETV) CEO John Lai’s transactions under a Rule 10b5-1 trading plan?
No. The filing indicates that these transactions were not made under a Rule 10b5-1 trading plan, meaning no pre-arranged trading plan is reported for these acquisitions and the warrant conversion.
What is the exercise price and expiration date of the PetVivo (PETV) warrants involved?
The warrants converted by John Lai relate to 31,250 underlying shares of PetVivo common stock, have an exercise price of $1.10 per share, and carry an expiration date of September 9, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
